Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for RSV-induced Respiratory Failure in Children
NCT05026749Phase 3Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Feb 2022
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in respiratory syncytial virus infection (RSV), sponsored by University of Alabama at Birmingham. Started Feb 2022; status: recruiting.
02
Drugs
azithromycin
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT05026749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05026749.